VRK2 targeting potentiates anti-PD-1 immunotherapy in hepatocellular carcinoma through MYC destabilization

Journal:
Nature Communications
Published:
DOI:
10.1038/s41467-025-64079-6
Affiliations:
5
Authors:
14
Go to article
Institutions Authors Share
Tongji Hospital (TJH), HUST, China
11.600000
11.600000
 0.83
MOE Key Laboratory of Organ Transplantation, HUST, China
2.400000
 0.17
Interested in Oncology and Carcinogenesis?